Categories AlphaGraphs, Earnings, Health Care
Infographic: How Bristol Myers Squibb (BMY) performed in Q4 2023 financial results
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today.
Total revenues inched up 1% to $11.5 billion versus the same period a year ago.
Net earnings attributable to BMS were $1.76 billion, or $0.87 per share, compared to $2 billion, or $0.95 per share, last year. Adjusted EPS decreased 7% to $1.70.
For full-year 2024, the company expects revenues to increase by low single-digits and adjusted EPS to range between $7.10-7.40.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln
